Tender

Various medicinal products

Original title: Biosimilars: Infliximab IV, Tocilizumab IV en SC, Denosumab SC en Epoëtine alfa

CountryBelgium
Deadline2026-12-01 (10 days left)
Published2026-11-03
SectorsHealth & life sciences
SourceTED - Tenders Electronic Daily (EU)

Summary

INFLIXIMAB IV

The buyer, the value, the full description and the link to the official notice are available with a free account.